Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HeartSciences (HSCS) Accounts Payables (2022 - 2025)

Historic Accounts Payables for HeartSciences (HSCS) over the last 4 years, with Q4 2025 value amounting to $317390.0.

  • HeartSciences' Accounts Payables rose 1464.41% to $317390.0 in Q4 2025 from the same period last year, while for Oct 2025 it was $317390.0, marking a year-over-year increase of 1464.41%. This contributed to the annual value of $318661.0 for FY2025, which is 2889.94% down from last year.
  • As of Q4 2025, HeartSciences' Accounts Payables stood at $317390.0, which was up 1464.41% from $283225.0 recorded in Q3 2025.
  • HeartSciences' 5-year Accounts Payables high stood at $1.1 million for Q4 2023, and its period low was $276848.0 during Q4 2024.
  • In the last 4 years, HeartSciences' Accounts Payables had a median value of $448183.0 in 2024 and averaged $534794.2.
  • Its Accounts Payables has fluctuated over the past 5 years, first surged by 3684.69% in 2023, then plummeted by 7456.14% in 2024.
  • Quarter analysis of 4 years shows HeartSciences' Accounts Payables stood at $795266.0 in 2022, then skyrocketed by 36.85% to $1.1 million in 2023, then plummeted by 74.56% to $276848.0 in 2024, then grew by 14.64% to $317390.0 in 2025.
  • Its Accounts Payables stands at $317390.0 for Q4 2025, versus $283225.0 for Q3 2025 and $318661.0 for Q2 2025.